vs
CENTERSPACE（CSR）与ORTHOPEDIATRICS CORP（KIDS）财务数据对比。点击上方公司名可切换其他公司
CENTERSPACE的季度营收约是ORTHOPEDIATRICS CORP的1.1倍（$65.1M vs $61.6M），ORTHOPEDIATRICS CORP净利率更高（-16.4% vs -23.0%，领先6.6%），ORTHOPEDIATRICS CORP同比增速更快（17.0% vs -3.0%），过去两年ORTHOPEDIATRICS CORP的营收复合增速更高（17.4% vs 0.0%）
Centerspace是一家专注于多户住宅物业持有、运营与开发的房地产投资企业，核心业务覆盖美国中西部及落基山西部区域，面向不同租户群体提供经济型及高端住宅选择，重视租户体验与资产长期价值增长。
OrthoPediatrics是一家美国生物科技企业，总部位于印第安纳州华沙，专注于设计、研发、生产并分销用于儿科诊疗的骨科植入物与手术器械。
CSR vs KIDS — 直观对比
营收规模更大
CSR
是对方的1.1倍
$61.6M
营收增速更快
KIDS
高出20.0%
-3.0%
净利率更高
KIDS
高出6.6%
-23.0%
两年增速更快
KIDS
近两年复合增速
0.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $65.1M | $61.6M |
| 净利润 | $-15.0M | $-10.1M |
| 毛利率 | — | 73.2% |
| 营业利润率 | — | -13.3% |
| 净利率 | -23.0% | -16.4% |
| 营收同比 | -3.0% | 17.0% |
| 净利润同比 | -258.1% | 37.1% |
| 每股收益（稀释后） | $-0.49 | $-0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSRKIDS
| Q1 26 | $65.1M | — | ||
| Q4 25 | $66.6M | $61.6M | ||
| Q3 25 | $71.4M | $61.3M | ||
| Q2 25 | $68.5M | $61.1M | ||
| Q1 25 | $67.1M | $52.4M | ||
| Q4 24 | $66.4M | $52.7M | ||
| Q3 24 | $65.0M | $54.6M | ||
| Q2 24 | $65.0M | $52.8M |
净利润CSRKIDS
| Q1 26 | $-15.0M | — | ||
| Q4 25 | $-18.4M | $-10.1M | ||
| Q3 25 | $53.8M | $-11.8M | ||
| Q2 25 | $-14.5M | $-7.1M | ||
| Q1 25 | $-3.7M | $-10.7M | ||
| Q4 24 | $-5.1M | $-16.1M | ||
| Q3 24 | $-1.0M | $-7.9M | ||
| Q2 24 | $-1.3M | $-6.0M |
毛利率CSRKIDS
| Q1 26 | — | — | ||
| Q4 25 | 96.5% | 73.2% | ||
| Q3 25 | 96.5% | 73.9% | ||
| Q2 25 | 96.5% | 72.1% | ||
| Q1 25 | 96.4% | 73.0% | ||
| Q4 24 | 96.5% | 67.5% | ||
| Q3 24 | 96.6% | 73.4% | ||
| Q2 24 | 96.6% | 77.3% |
营业利润率CSRKIDS
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | -13.3% | ||
| Q3 25 | — | -15.4% | ||
| Q2 25 | -9.9% | -17.4% | ||
| Q1 25 | 7.1% | -21.0% | ||
| Q4 24 | 4.3% | -26.7% | ||
| Q3 24 | 9.8% | -10.2% | ||
| Q2 24 | 11.1% | -10.7% |
净利率CSRKIDS
| Q1 26 | -23.0% | — | ||
| Q4 25 | -27.7% | -16.4% | ||
| Q3 25 | 75.3% | -19.2% | ||
| Q2 25 | -21.2% | -11.6% | ||
| Q1 25 | -5.6% | -20.3% | ||
| Q4 24 | -7.6% | -30.5% | ||
| Q3 24 | -1.6% | -14.5% | ||
| Q2 24 | -2.0% | -11.4% |
每股收益（稀释后）CSRKIDS
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-1.08 | $-0.43 | ||
| Q3 25 | $3.19 | $-0.50 | ||
| Q2 25 | $-0.87 | $-0.30 | ||
| Q1 25 | $-0.22 | $-0.46 | ||
| Q4 24 | $-0.31 | $-0.70 | ||
| Q3 24 | $-0.40 | $-0.34 | ||
| Q2 24 | $-0.19 | $-0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.6M | $60.9M |
| 总债务越低越好 | — | $106.0M |
| 股东权益账面价值 | $695.0M | $346.6M |
| 总资产 | $1.9B | $508.6M |
| 负债/权益比越低杠杆越低 | — | 0.31× |
8季度趋势，按日历期对齐
现金及短期投资CSRKIDS
| Q1 26 | $7.6M | — | ||
| Q4 25 | $12.8M | $60.9M | ||
| Q3 25 | $12.9M | $57.7M | ||
| Q2 25 | $12.4M | $70.1M | ||
| Q1 25 | $11.9M | $58.8M | ||
| Q4 24 | $12.0M | $68.8M | ||
| Q3 24 | $14.5M | $76.1M | ||
| Q2 24 | $14.3M | $28.9M |
总债务CSRKIDS
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $106.0M | ||
| Q3 25 | $1.1B | $105.3M | ||
| Q2 25 | $1.1B | $102.7M | ||
| Q1 25 | $955.5M | $77.4M | ||
| Q4 24 | $955.4M | $77.5M | ||
| Q3 24 | $921.3M | $76.9M | ||
| Q2 24 | $931.7M | $11.2M |
股东权益CSRKIDS
| Q1 26 | $695.0M | — | ||
| Q4 25 | $719.2M | $346.6M | ||
| Q3 25 | $748.6M | $349.3M | ||
| Q2 25 | $710.1M | $355.5M | ||
| Q1 25 | $636.8M | $347.1M | ||
| Q4 24 | $752.0M | $354.6M | ||
| Q3 24 | $672.5M | $370.9M | ||
| Q2 24 | $680.7M | $371.3M |
总资产CSRKIDS
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.9B | $508.6M | ||
| Q3 25 | $2.1B | $493.5M | ||
| Q2 25 | $2.0B | $503.6M | ||
| Q1 25 | $1.9B | $470.3M | ||
| Q4 24 | $1.9B | $473.2M | ||
| Q3 24 | $1.9B | $489.3M | ||
| Q2 24 | $1.9B | $430.8M |
负债/权益比CSRKIDS
| Q1 26 | — | — | ||
| Q4 25 | 1.42× | 0.31× | ||
| Q3 25 | 1.53× | 0.30× | ||
| Q2 25 | 1.57× | 0.29× | ||
| Q1 25 | 1.50× | 0.22× | ||
| Q4 24 | 1.27× | 0.22× | ||
| Q3 24 | 1.37× | 0.21× | ||
| Q2 24 | 1.37× | 0.03× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $10.3M |
| 自由现金流经营现金流 - 资本支出 | — | $9.7M |
| 自由现金流率自由现金流/营收 | — | 15.8% |
| 资本支出强度资本支出/营收 | 0.3% | 1.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-16.0M |
8季度趋势，按日历期对齐
经营现金流CSRKIDS
| Q1 26 | — | — | ||
| Q4 25 | $98.5M | $10.3M | ||
| Q3 25 | $35.1M | $-581.0K | ||
| Q2 25 | $25.3M | $-10.5M | ||
| Q1 25 | $25.4M | $-4.2M | ||
| Q4 24 | $98.2M | $-4.0M | ||
| Q3 24 | $32.3M | $-10.3M | ||
| Q2 24 | $22.9M | $-6.1M |
自由现金流CSRKIDS
| Q1 26 | — | — | ||
| Q4 25 | $64.3M | $9.7M | ||
| Q3 25 | $25.7M | $-3.4M | ||
| Q2 25 | $15.5M | $-13.9M | ||
| Q1 25 | $20.4M | $-8.4M | ||
| Q4 24 | $41.6M | $-4.2M | ||
| Q3 24 | $20.5M | $-11.7M | ||
| Q2 24 | $9.1M | $-12.8M |
自由现金流率CSRKIDS
| Q1 26 | — | — | ||
| Q4 25 | 96.5% | 15.8% | ||
| Q3 25 | 36.0% | -5.6% | ||
| Q2 25 | 22.7% | -22.8% | ||
| Q1 25 | 30.4% | -16.0% | ||
| Q4 24 | 62.6% | -8.1% | ||
| Q3 24 | 31.5% | -21.4% | ||
| Q2 24 | 14.0% | -24.2% |
资本支出强度CSRKIDS
| Q1 26 | 0.3% | — | ||
| Q4 25 | 51.3% | 1.0% | ||
| Q3 25 | 13.1% | 4.6% | ||
| Q2 25 | 14.2% | 5.6% | ||
| Q1 25 | 7.5% | 8.1% | ||
| Q4 24 | 85.3% | 0.5% | ||
| Q3 24 | 18.2% | 2.5% | ||
| Q2 24 | 21.2% | 12.7% |
现金转化率CSRKIDS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
